In today’s briefing:
- Biocon Biologics – Earnings Flash – Q4 And FY 2024-25 Results – Lucror Analytics
- Lucror Analytics – Morning Views Asia
- UPL Limited – Earnings Flash – FY 2024-25 Results – Lucror Analytics
Biocon Biologics – Earnings Flash – Q4 And FY 2024-25 Results – Lucror Analytics
- Biocon Limited’s Q4 and FY 2024-25 results were solid in our view, with robust growth, stable profitability, as well as improved working capital and cash flows.
- The balance sheet has strengthened, and liquidity is adequate.
Lucror Analytics – Morning Views Asia
- In today’s Morning Views publication we comment on developments of the following high yield issuers: Seazen Group, Softbank Group
In the US, the April CPI came in below expectations for the third straight month at 2.3% y-o-y (2.4% e / 2.4% p) and 0.2% m-o-m (0.3% e / -0.1% p). Core CPI (excluding food and energy) stood at 2.8% y-o-y (2.8% e / 2.8% p) and 0.2% m-o-m (0.3% e / 0.1% p).
Treasuries were largely steady yesterday, as supply pressure from corporate issuances offset the softer than expected April CPI print.
UPL Limited – Earnings Flash – FY 2024-25 Results – Lucror Analytics
- UPL Limited’s Q4 and FY 2024-25 results reflected robust revenue growth, substantial margin expansion, a return to profitability and significant debt reduction.
- This was supported by strong operational execution and strategic initiatives across its global markets.
- Leverage improved significantly, on account of much lower net debt and higher earnings.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
